MedPath

A CLINICAL TRIAL TO STUDY THE EFFECT OF A MULTIPAL DRUG FORMULATION, SHALLAKIADI YOGA IN AMAVATA (RHEUMATOID ARTHRITIS)

Phase 2
Conditions
Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor
Registration Number
CTRI/2022/07/044321
Lead Sponsor
SDM COLLEGE OF AYURVEDA AND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Amavata with features of Rheumatoid Arthritis as specified in 2010 ACR-EULAR classification criteria for Rheumatoid Arthritis with less than 5 years of chronicity (Parameters in ACR-EULAR criteria: Duration of symptoms, joint distribution, serology, acute phase reactants)

2. Subjects aged between 18 -75 years

3. Subjects of either gender

4. Subjects willing to participate in the study and ready to sign informed consent form

Exclusion Criteria

1. Subjects with known case of uncontrolled hypertension, diabetes mellitus, renal, hepatic and cardiac function

2. Subjects with known case of Systemic arthritis (gout, tubercular arthritis, systemic lupus erythematosus, psoriatic arthritis)

3. Pregnant and lactating women

4. Subjects used/using Steroids more than 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath